Extracellular matrix composition in COPD
- PMID: 22496324
- DOI: 10.1183/09031936.00192611
Extracellular matrix composition in COPD
Abstract
Extracellular matrix (ECM) composition has an important role in determining airway structure. We postulated that ECM lung composition of chronic obstructive pulmonary disease (COPD) patients differs from that observed in smoking and nonsmoking subjects without airflow obstruction. We determined the fractional areas of elastic fibres, type-I, -III and -IV collagen, versican, decorin, biglycan, lumican, fibronectin and tenascin in different compartments of the large and small airways and lung parenchyma in 26 COPD patients, 26 smokers without COPD and 16 nonsmoking control subjects. The fractional area of elastic fibres was higher in non-obstructed smokers than in COPD and nonsmoking controls, in all lung compartments. Type-I collagen fractional area was lower in the large and small airways of COPD patients and in the small airways of non-obstructed smokers than in nonsmokers. Compared with nonsmokers, COPD patients had lower versican fractional area in the parenchyma, higher fibronectin fractional area in small airways and higher tenascin fractional area in large and small airways compartments. In COPD patients, significant correlations were found between elastic fibres and fibronectin and lung function parameters. Alterations of the major ECM components are widespread in all lung compartments of patients with COPD and may contribute to persistent airflow obstruction.
Similar articles
-
The lung extracellular matrix protein landscape in severe early-onset and moderate chronic obstructive pulmonary disease.Am J Physiol Lung Cell Mol Physiol. 2024 Sep 1;327(3):L304-L318. doi: 10.1152/ajplung.00332.2023. Epub 2024 Jun 25. Am J Physiol Lung Cell Mol Physiol. 2024. PMID: 38915286
-
Proteoglycans and diseases of soft tissues.Adv Exp Med Biol. 2014;802:49-58. doi: 10.1007/978-94-007-7893-1_4. Adv Exp Med Biol. 2014. PMID: 24443020 Review.
-
Airway proteoglycans are differentially altered in fatal asthma.J Pathol. 2005 Sep;207(1):102-10. doi: 10.1002/path.1818. J Pathol. 2005. PMID: 16041692
-
A comprehensive map of proteoglycan expression and deposition in the pulmonary arterial wall in health and pulmonary hypertension.Am J Physiol Lung Cell Mol Physiol. 2024 Aug 1;327(2):L173-L188. doi: 10.1152/ajplung.00022.2024. Epub 2024 May 21. Am J Physiol Lung Cell Mol Physiol. 2024. PMID: 38771138
-
The role of SLRP-proteoglycans in osteosarcoma pathogenesis.Connect Tissue Res. 2008;49(3):235-8. doi: 10.1080/03008200802147589. Connect Tissue Res. 2008. PMID: 18661350 Review.
Cited by
-
Impaired Differentiation of Chronic Obstructive Pulmonary Disease Bronchial Epithelial Cells Grown on Bronchial Scaffolds.Am J Respir Cell Mol Biol. 2021 Aug;65(2):201-213. doi: 10.1165/rcmb.2019-0395OC. Am J Respir Cell Mol Biol. 2021. PMID: 33882260 Free PMC article.
-
Advanced glycation endproducts and their receptor in different body compartments in COPD.Respir Res. 2016 Apr 26;17:46. doi: 10.1186/s12931-016-0363-2. Respir Res. 2016. PMID: 27117828 Free PMC article. Clinical Trial.
-
Endoplasmic reticulum stress and glutathione therapeutics in chronic lung diseases.Redox Biol. 2020 Jun;33:101516. doi: 10.1016/j.redox.2020.101516. Epub 2020 Mar 23. Redox Biol. 2020. PMID: 32249209 Free PMC article. Review. No abstract available.
-
Central airways remodeling in COPD patients.Int J Chron Obstruct Pulmon Dis. 2014 Sep 1;9:927-32. doi: 10.2147/COPD.S52478. eCollection 2014. Int J Chron Obstruct Pulmon Dis. 2014. PMID: 25214779 Free PMC article.
-
Disease-associated gut microbiome and metabolome changes in patients with chronic obstructive pulmonary disease.Nat Commun. 2020 Nov 18;11(1):5886. doi: 10.1038/s41467-020-19701-0. Nat Commun. 2020. PMID: 33208745 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous